Diabetes disproportionately affects Native Communities in the US who experience high rates of related health complications. While several Native-led health...

Technologies like CGM and insulin pumps have the potential to revolutionize a person’s diabetes care and management. Unfortunately, too many...

Time in Range, a metric most often calculated using a CGM, is a valuable glucose management tool that people with...

diaTribe partnered with Abbott and Novo Nordisk to bring you the Time in Range Hub – a new online resource...

The FDA has denied approval of teplizumab, the first disease-modifying drug that could prevent the onset of type 1 diabetes....

On May 18, 2021, diaTribe joined with over 30 other organizations to call on California’s Senate and Assembly leaders to...

President Biden proposed a new agency within the NIH geared to developing new therapies for diabetes. Read below to find...